Ventana Medical Systems Inc., of Tucson, Ariz., a member of the Roche Group, said it inked a multiyear deal with Bayer AG, of Leverkusen, Germany, to develop companion diagnostics, with a focus on immunohistochemistry, across Bayer’s portfolio of targeted therapy projects.